Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

Metatarsal Stem, Small
OSTEOMED LLC
370-0223
In Commercial Distribution

  • 00845694011334 ()

  • Length: 25 Millimeter
370-0223

  • Partial metatarsophalangeal joint prosthesis
Metatarsal Head, Extra Long
OSTEOMED LLC
370-0207
In Commercial Distribution

  • 00845694011327 ()

  • Outer Diameter: 19 Millimeter
370-0207

  • Partial metatarsophalangeal joint prosthesis
Metatarsal Head, Long
OSTEOMED LLC
370-0205
In Commercial Distribution

  • 00845694011310 ()

  • Outer Diameter: 18 Millimeter
370-0205

  • Partial metatarsophalangeal joint prosthesis
Metatarsal Head, Standard
OSTEOMED LLC
370-0203
In Commercial Distribution

  • 00845694011303 ()

  • Outer Diameter: 17 Millimeter
370-0203

  • Partial metatarsophalangeal joint prosthesis
The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL090A
In Commercial Distribution

  • 14540778171395 ()
  • 04540778171398 ()

  • Length: 90 Millimeter


  • Lacrimal tube
The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL105A
In Commercial Distribution

  • 04540778171381 ()
  • 14540778171388 ()

  • Length: 105 Millimeter


  • Lacrimal tube
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R090A
In Commercial Distribution

  • 04540778140875 ()
  • 14540778140872 ()

  • Length: 90 Millimeter


  • Lacrimal tube
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R105A
In Commercial Distribution

  • 04540778140868 ()
  • 14540778140865 ()

  • Length: 105 Millimeter


  • Lacrimal tube
PRONTOSAN SOLUTION RF "US" 350ML-STERIL
B. BRAUN MEDICAL INC.
400454
In Commercial Distribution

  • 04046955726479 ()
  • 04046955726486 ()

  • Volume : 350.000 ML
400454

  • Antimicrobial wound irrigation solution
Simplee® Retraction Paste (Lifco) (Pkg. of 30 Capsules)
PARKELL, INC.
156215
In Commercial Distribution

  • 00810000525713 ()
  • 10810000525710 ()
156215

  • Gingival retraction cord, non-medicated
< 1 2 3 4 5 ... 25 >